Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04683510 · ClinicalTrials.gov registry record · NA
Awareness Enhancing Interventions
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 4,451
- Enrollment target
NCT04683510: Completed NA study, sponsored by University of Tennessee.
NCT04683510 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 4,451 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (217% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04683510, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,451 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if increasing awareness and, thus, enhancing positive attitudes about research, prior to recruitment attempts, will increase participation in cancer clinical research among African American (AA) cancer survivors so that recruitment efforts can focus on the most optimal and cost- effective approaches
Primary Outcome
measured by the proportion of targeted survivors who, at the time of the recruitment call, after the screening process is complete, decide to participate in AMPLIFI.
Interventions
- OTHER Navigation - Study Specific - Researcher Voice
- OTHER Navigation - Study Specific - Cancer Survivor Voice
- OTHER Navigation - Research General - Researcher Voice
- OTHER Navigation - Research General - Cancer Survivor Voice
- OTHER Brochure - Study Specific - Researcher Voice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,451 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT04683510 record still lists
NCT04683510 is an interventional study that assigns participants to a tested intervention. Its 4,451 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (217% higher).
The record links to 0 conditions, and to 5 interventions - of which Navigation - Study Specific - Researcher Voice is the first listed.
NCT04683510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04683510 about?
NCT04683510 is a clinical study titled "Awareness Enhancing Interventions". The purpose of this study is to determine if increasing awareness and, thus, enhancing positive attitudes about research, prior to recruitment attempts, will increase participation in cancer clinical research among African American (AA) cancer survivors so that recruitment efforts can focus on the m...
What is the current status of trial NCT04683510?
This trial is currently completed. It is a NA study. The enrollment target is 4,451 participants. The study started on 2021-04-12. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04683510?
The interventions under investigation include: Navigation - Study Specific - Researcher Voice (OTHER), Navigation - Study Specific - Cancer Survivor Voice (OTHER), Navigation - Research General - Researcher Voice (OTHER), Navigation - Research General - Cancer Survivor Voice (OTHER), Brochure - Study Specific - Researcher Voice (OTHER).
Who is sponsoring clinical trial NCT04683510?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04683510's enrollment target sits among peer trials
4,451 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI